Inaedis, Inc. is a spin-out company from Princeton University developing a pharmaceutical platform changing the future of drug development, delivery, and distribution by powderizing life-saving vaccines and biologics.
First developed by Princeton scientists during the Covid-19 pandemic, our goal is to give everyone access to the miracles of modern medicine. Our proprietary Rapid Room-Temperature Dehydration (RTAD) platform technology finally solves the global dilemma posed by the thermal stabilization requirements of life-saving heat and freeze-sensitive vaccines and biologics.
Inaedis is led by its founders: CEO Dr. Maksim Mezhericher and Prof. Howard A. Stone and is backed by Roadrunner Venture Studios and Princeton Innovation Center.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 303a College Rd E, Princeton,new Jersey 08540,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.inaedis.com
- Keywords
- Chemical Engineering, Biopharma, Biotechnology, Thermal stabilization of biologics and vaccines, Mechanical Engineering, Drying Technology.
- HQ
- Princeton, New Jersey
Inaedis, Inc. Questions
Inaedis, Inc.'s website is http://www.inaedis.com
Inaedis, Inc.'s LinkedIn profile is https://www.linkedin.com/company/inaedis
Inaedis, Inc. has
4 employees.
View email and phone details for 4
employees at Inaedis, Inc..
Inaedis, Inc.'s industry is
Biotechnology Research
Inaedis, Inc.'s top competitors are
Resync Bio,
Esya Labs,
Ubiquitx, Inc.,
Augment Biologics,
Nine Diagnostics,
Potato,
Hebbian Bio,
Voyant Bio,
Modernvivo,
Imyoo.
Inaedis, Inc.'s categories are Biotechnology Research
Inaedis, Inc.'s founding year is 2022
